These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 31325350)

  • 21. Chronic inflammatory demyelinating polyradiculoneuropathy in children: I. Presentation, electrodiagnostic studies, and initial clinical course, with comparison to adults.
    Simmons Z; Wald JJ; Albers JW
    Muscle Nerve; 1997 Aug; 20(8):1008-15. PubMed ID: 9236792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence and Prevalence of Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Systematic Review and Meta-Analysis.
    Broers MC; Bunschoten C; Nieboer D; Lingsma HF; Jacobs BC
    Neuroepidemiology; 2019; 52(3-4):161-172. PubMed ID: 30669140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Idiopathic chronic inflammatory demyelinating polyneuropathy: an epidemiological study in Italy.
    Chiò A; Cocito D; Bottacchi E; Buffa C; Leone M; Plano F; Mutani R; Calvo A;
    J Neurol Neurosurg Psychiatry; 2007 Dec; 78(12):1349-53. PubMed ID: 17494979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibronectin connecting segment-1 peptide inhibits pathogenic leukocyte trafficking and inflammatory demyelination in experimental models of chronic inflammatory demyelinating polyradiculoneuropathy.
    Dong C; Greathouse KM; Beacham RL; Palladino SP; Helton ES; Ubogu EE
    Exp Neurol; 2017 Jun; 292():35-45. PubMed ID: 28215575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective study of the additional benefit of plexus magnetic resonance imaging in the diagnosis of chronic inflammatory demyelinating polyneuropathy.
    Jomier F; Bousson V; Viala K; Péréon Y; Magot A; Cauquil C; Bouhour F; Vial C; Bedat-Millet AL; Taithe F; Bresch S; Siri A; Kubis N; Lozeron P
    Eur J Neurol; 2020 Jan; 27(1):181-187. PubMed ID: 31348848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated leukocyte count in cerebrospinal fluid of patients with chronic inflammatory demyelinating polyneuropathy.
    Lucke IM; Peric S; van Lieverloo GGA; Wieske L; Verhamme C; van Schaik IN; Basta I; Eftimov F
    J Peripher Nerv Syst; 2018 Mar; 23(1):49-54. PubMed ID: 29341326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blink R1 latency utility in diagnosis and treatment assessment of polyradiculoneuropathy-organomegaly-endocrinopathy-monoclonal protein-skin changes and chronic inflammatory demyelinating polyradiculoneuropathy.
    Wang W; Litchy WJ; Mauermann ML; Dyck PJB; Dispenzieri A; Mandrekar J; Dyck PJ; Klein CJ
    Muscle Nerve; 2018 Jan; 57(1):E8-E13. PubMed ID: 28646568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression Analysis of Protein Inhibitor of Activated STAT in Inflammatory Demyelinating Polyradiculoneuropathy.
    Ghafouri-Fard S; Hussen BM; Nicknafs F; Nazer N; Sayad A; Taheri M
    Front Immunol; 2021; 12():659038. PubMed ID: 34054823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP): Clinical Features, Diagnosis, and Current Treatment Strategies.
    Reynolds J; Sachs G; Stavros K
    R I Med J (2013); 2016 Dec; 99(12):32-35. PubMed ID: 27902997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does the chronic inflammatory demyelinating polyradiculoneuropathy due to secondary cause differ from primary?
    Wadwekar V; Kalita J; Misra UK
    Neurol India; 2011; 59(5):664-8. PubMed ID: 22019647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Employment status of patients with chronic inflammatory demyelinating polyradiculoneuropathy.
    Bjelica B; Basta I; Bozovic I; Kacar A; Nikolic A; Dominovic-Kovacevic A; Vukojevic Z; Martic V; Stojanov A; Djordjevic G; Petrovic M; Stojanovic M; Peric S
    J Peripher Nerv Syst; 2018 Sep; 23(3):178-182. PubMed ID: 29999199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic acquired demyelinating symmetric polyneuropathy classified by pattern of weakness.
    Mygland A; Monstad P
    Arch Neurol; 2003 Feb; 60(2):260-4. PubMed ID: 12580713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subacute inflammatory demyelinating polyneuropathy.
    Oh SJ; Kurokawa K; de Almeida DF; Ryan HF; Claussen GC
    Neurology; 2003 Dec; 61(11):1507-12. PubMed ID: 14663033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic inflammatory demyelinating polyradiculoneuropathy and anesthesia: a case series.
    Mortenson AR; Sprung J; Watson JC; Dyck PJB; Weingarten TN
    Acta Neurol Belg; 2017 Dec; 117(4):895-901. PubMed ID: 28936613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Demyelinating neuropathy in diabetes mellitus.
    Sharma KR; Cross J; Farronay O; Ayyar DR; Shebert RT; Bradley WG
    Arch Neurol; 2002 May; 59(5):758-65. PubMed ID: 12020257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Juvenile Chronic Inflammatory Demyelinating Polyneuropathy Epidemiology in Sardinia, Insular Italy.
    Sotgiu S; Onida I; Magli G; Castiglia P; Conti M; Nuvoli A; Carta A; Festa S; Dessì V; Doneddu PE; Nobile-Orazio E
    Neuropediatrics; 2021 Feb; 52(1):56-61. PubMed ID: 33111308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic inflammatory demyelinating polyradiculoneuropathy and variants: where we are and where we should go.
    Nobile-Orazio E
    J Peripher Nerv Syst; 2014 Mar; 19(1):2-13. PubMed ID: 24612201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disease activity in chronic inflammatory demyelinating polyneuropathy: A comparative study of clinical and skin biopsy markers.
    Acarli ANÖ; Ünverengil G; Şirin NG; Çakar A; Durmuş H; Parman Y
    Muscle Nerve; 2022 Dec; 66(6):736-743. PubMed ID: 36151750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical factors, diagnostic delay, and residual deficits in chronic inflammatory demyelinating polyradiculoneuropathy.
    Bunschoten C; Blomkwist-Markens PH; Horemans A; van Doorn PA; Jacobs BC
    J Peripher Nerv Syst; 2019 Sep; 24(3):253-259. PubMed ID: 31410938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.
    Mahdi-Rogers M; Brassington R; Gunn AA; van Doorn PA; Hughes RA
    Cochrane Database Syst Rev; 2017 May; 5(5):CD003280. PubMed ID: 28481421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.